The cytokine network in RA is complex; pro-inflammatory cytokines, including tumor necrosis factor (TNF)-α, interleukin (IL)-6 and the mediators produced through downstream pathways constitute the milieu driving neoangiogenesis. This evidence concerns the gene IL6 and rheumatoid arthritis.